Comparison of pharmacokinetic characteristics of two Tegoprazan (CJ-12420) formulations in healthy male subjects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of pharmacokinetic characteristics of two Tegoprazan (CJ-12420) formulations in healthy male subjects

Published:2019 Issue:2 Volume:27 Page:80
ISSN:2289-0882
Container-title:Translational and Clinical Pharmacology
language:en
Short-container-title:Transl Clin Pharmacol

Author:

Hwang Jun Gi¹,Yoo Hyounggyoon¹,Lee Ji Won²,Song Geun Seog²,Lee SeungHwan¹,Kim Min-Gul³

Affiliation:

1. Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul 03080, Republic of Korea.

2. Clinical Development Division, CJ HealthCare Corp., Seoul 04551, Republic of Korea.

3. Department of Pharmacology, School of Medicine, Chonbuk National University, Jeonju 54907, Republic of Korea.

Funder

CJ HealthCare Corp

Publisher

Korean Society for Clinical Pharmacology and Therapeutics

Subject

Pharmacology (medical)

Link

https://synapse.koreamed.org/pdf/10.12793/tcp.2019.27.2.80

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic Interactions Between Tegoprazan and the Combination of Clarithromycin, Amoxicillin and Bismuth in Healthy Chinese Subjects: An Open-Label, Single-Center, Multiple-Dosage, Self-Controlled, Phase I Trial;Clinical Drug Investigation;2024-04-13

2. Tegoprazan as a New Remedy for Gastrointestinal Diseases in Comparison with its Therapeutic Predecessors: A Mini-Review;Current Drug Research Reviews;2024-03

3. Evaluation of the comparative pharmacokinetic properties of a new orally disintegrating tablet of tegoprazan in healthy Korean subjects;Int. Journal of Clinical Pharmacology and Therapeutics;2023-09-01

4. Pharmacokinetic and pharmacodynamic exploration of various combinations of tegoprazan immediate and delayed‐release formulations;British Journal of Clinical Pharmacology;2023-06

5. JP‐1366: A novel and potent potassium‐competitive acid blocker that is effective in the treatment of acid‐related diseases;Pharmacology Research & Perspectives;2023-05-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3